Vascular inflammation in cerebral small vessel disease

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1800-1806

  Rouhl, Rob P W ^a   Damoiseaux, Jan G M C ^a   Lodder, Jan ^a,b   Theunissen, Ruud O M F I H ^a   Knottnerus, Iris L H ^a   Staals, Julie ^a,b   Henskens, Léon H G ^a   Kroon, Abraham A ^a,b   de Leeuw, Peter W ^a,b   Tervaert, Jan Willem Cohen ^a,b   van Oostenbrugge, Robert J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adhesion molecules; Cerebral small vessel disease; Lacunar infarcts; Neopterin; White matter lesions

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; NEOPTERIN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN RADIOGRAPHY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LACUNAR STROKE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULITIS; VIRCHOW ROBIN SPACE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; CEREBRAL SMALL VESSEL DISEASES; FEMALE; HUMANS; MACROPHAGE ACTIVATION; MALE; MICROVESSELS; MIDDLE AGED; NEOPTERIN; VASCULITIS; YOUNG ADULT;

EID: 84861882737     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.04.008     Document Type: Article

References (43)

1. Baezner H., Blahak C., Poggesi A., Pantoni L., Inzitari D., Chabriat H., Erkinjuntti T., Fazekas F., Ferro J.M., Langhorne P., O'Brien J., Scheltens P., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Hennerici M.G. Association of gait and balance disorders with age-related white matter changes: The LADIS study. Neurology 2008, 70:935-942. LADIS Study Group.
2. Boiten J., Lodder J., Kessels F. Two clinically distinct lacunar infarct entities?. A hypothesis. Stroke 1993, 24:652-656.
3. Castellanos M., Castillo J., García M.M., Leira R., Serena J., Chamorro A., Dávalos A. Inflammation-mediated damage in progressing lacunar infarctions: A potential therapeutic target. Stroke 2002, 33:982-987.
4. Cirillo P., Pacileo M., DE Rosa S., Calabrò P., Gargiulo A., Angri V., Granato-Corigliano F., Fiorentino I., Prevete N., DE Palma R., Mauro C., Leonardi A., Chiariello M. Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells. J. Thromb. Haemost 2006, 4:2248-2255.
5. Constans J., Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin. Chim. Acta 2006, 368:33-47.
6. de Jong G., Kessels F., Lodder J. Two types of lacunar infarcts: Further arguments from a study on prognosis. Stroke 2002, 33:2072-2076.
7. de Leeuw F.E., de Kleine M., Frijns C.J., Fijnheer R., van Gijn J., Kappelle L.J. Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann. N. Y. Acad. Sci 2002, 977:306-314.
8. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 2007, 115:1285-1295.
9. Farrall A.J., Wardlaw J.M. Blood-brain barrier: Ageing and microvascular disease--systematic review and meta-analysis. Neurobiol. Aging 2009, 30:337-352.
10. Fassbender K., Bertsch T., Mielke O., Mühlhauser F., Hennerici M. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999, 30:1647-1650.
11. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol 1987, 149:351-356.
12. Fuchs D., Weiss G., Reibnegger G., Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit. Rev. Clin. Lab. Sci 1992, 29:307-341.
13. Garde E., Lykke-Mortensen E., Rostrup E., Paulson O.B. Decline in intelligence is associated with progression in white matter hyperintensity volume. J. Neurol. Neurosurg. Psychiatry 2005, 76:1289-1291.
14. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol 1998, 16:225-260.
15. Gottesman R.F., Coresh J., Catellier D.J., Sharrett A.R., Rose K.M., Coker L.H., Shibata D.K., Knopman D.S., Jack C.R., Mosley T.H. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010, 41:3-8.
16. Grau A.J., Reis A., Buggle F., Al-Khalaf A., Werle E., Valois N., Bertram M., Becher H., Grond-Ginsbach C. Monocyte function and plasma levels of interleukin-8 in acute ischemic stroke. J. Neurol. Sci 2001, 192:41-47.
17. Han J.H., Wong K.S., Wang Y.Y., Fu J.H., Ding D., Hong Z. Plasma level of sicam-1 is associated with the extent of white matter lesion among asymptomatic elderly subjects. Clin. Neurol. Neurosurg 2009, 111:847-851.
18. Hassan A., Hunt B.J., O'Sullivan M., Parmar K., Bamford J.M., Briley D., Brown M.M., Thomas D.J., Markus H.S. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126:424-432.
19. Henskens L.H., Kroon A.A., van Oostenbrugge R.J., Gronenschild E.H., Fuss-Lejeune M.M., Hofman P.A., Lodder J., de Leeuw P.W. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension 2008, 52:1120-1126.
20. Hoffmann G. More on: Neopterin induces the proatherothrombotic phenotype in human coronary endothelial cells. J. Thromb. Haemost 2007, 5:211-212.
21. Knottnerus I.L., Ten Cate H., Lodder J., Kessels F., van Oostenbrugge R.J. Endothelial dysfunction in lacunar stroke: A systematic review. Cerebrovasc. Dis 2009, 27:519-526.
22. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003, 169:203-214.
23. Markus H.S., Hunt B., Palmer K., Enzinger C., Schmidt H., Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the austrian stroke prevention study. Stroke 2005, 36:1410-1414.
24. Muller Kobold A.C., Kallenberg C.G., Tervaert J.W. Monocyte activation in patients with wegener's granulomatosis. Ann. Rheum. Dis 1999, 58:237-245.
25. Poggesi A., Pracucci G., Chabriat H., Erkinjuntti T., Fazekas F., Verdelho A., Hennerici M., Langhorne P., O'Brien J., Scheltens P., Visser M.C., Crisby M., Waldemar G., Wallin A., Inzitari D., Pantoni L. Urinary complaints in nondisabled elderly people with age-related white matter changes: The Leukoaraiosis And DISability (LADIS) study. J. Am. Geriatr. Soc 2008, 56:1638-1643. Leukoaraiosis And DISability Study Group.
26. Reed B.R., Eberling J.L., Mungas D., Weiner M., Kramer J.H., Jagust W.J. Effects of white matter lesions and lacunes on cortical function. Arch. Neurol 2004, 61:1545-1550.
27. Rothkrantz-Kos S., Bekers O., Gubbels A., Drent M., Schmitz M.P., van Dieijen-Visser M.P. Evaluation of two new high-sensitivity methods for c-reactive protein. Ann. Clin. Biochem 2003, 40:398-405.
28. Rouhl R.P., van Oostenbrugge R.J., Knottnerus I.L., Staals J.E., Lodder J. Virchow-Robin spaces relate to cerebral small vessel disease severity. J. Neurol 2008, 255:692-696.
29. Rouhl R.P.W., van Oostenbrugge R.J., Damoiseaux J.G.M.C., Debrus-Palmans L.L., Theunissen R.O.M.F.I.H., Knottnerus I.L.H., Staals J.E.A., Delanghe J.R., Tervaert J.W., Lodder J. Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr. Neurovasc Res 2009, 6:32-41.
30. Rouhl R.P.W., Van Oostenbrugge R.J., Lodder J. White matter lesions: from present to future. Handbook on White Matter; Structure, Function and Changes 2009, 17-28. Nova, New York. T.B. Westland, R.N. Calton (Eds.).
31. Schmidt R., Schmidt H., Pichler M., Enzinger C., Petrovic K., Niederkorn K., Horner S., Ropele S., Watzinger N., Schumacher M., Berghold A., Kostner G.M., Fazekas F. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: Results of the austrian stroke prevention study. Stroke 2006, 37:2910-2916.
32. Schroecksnadel K., Frick B., Winkler C., Fuchs D. Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr. Vasc. Pharmacol 2006, 4:205-213.
33. Schubert S.Y., Benarroch A., Monter-Solans J., Edelman E.R. Monocyte activation state regulates monocyte-induced endothelial proliferation through met signaling. Blood 2010, 115. 3407-2412.
34. Tervaert J.W., Kallenberg C.G. Cell adhesion molecules in vasculitis. Curr. Opin. Rheumatol 1997, 9:16-25.
35. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., Weiner M.W., Chui H.C., Jagust W.J. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004, 63:246-253.
36. van Dijk E.J., Prins N.D., Vrooman H.A., Hofman A., Koudstaal P.J., Breteler M.M. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam scan study. Stroke 2008, 39:2712-2719.
37. van Haelst P.L., Liem A., van Boven A.J., Veeger N.J., van Veldhuisen D.J., Tervaert J.W., Gans R.O., Zijlstra F. Usefulness of elevated neopterin and c-reactive protein levels in predicting cardiovascular events in patients with non-q-wave myocardial infarction. Am. J. Cardiol 2003, 92:1201-1203.
38. van Straaten E.C., Fazekas F., Rostrup E., Scheltens P., Schmidt R., Pantoni L., Inzitari D., Waldemar G., Erkinjuntti T., Mäntylä R., Wahlund L.O., Barkhof F. Impact of white matter hyperintensities scoring method on correlations with clinical data: The LADIS study. Stroke 2006, 37:836-840. LADIS Group.
39. Vernooij M.W., van der Lugt A., Ikram M.A., Wielopolski P.A., Niessen W.J., Hofman A., Krestin G.P., Breteler M.M. Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology 2008, 70:1208-1214.
40. Wardlaw J.M., Sandercock P.A., Dennis M.S., Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 2003, 34:806-812.
41. Wen H.M., Mok V.C., Fan Y.H., Lam W.W., Tang W.K., Wong A., Huang R.X., Wong K.S. Effect of white matter changes on cognitive impairment in patients with lacunar infarcts. Stroke 2004, 35:1826-1830.
42. Wiszniewska M., Devuyst G., Bogousslavsky J., Ghika J., van Melle G. What is the significance of leukoaraiosis in patients with acute ischemic stroke?. Arch. Neurol 2000, 57:967-973.
43. Wuerfel J., Haertle M., Waiczies H., Tysiak E., Bechmann I., Wernecke K.D., Zipp F., Paul F. Perivascular spaces--MRI marker of inflammatory activity in the brain?. Brain 2008, 131:2332-2340.